Thomas Edwards, MD
Otolaryngic Allergy · Decatur, GANPI 1821451345
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,912 of the $4,361 with a category attached, or 89.7%. Sanofi accounts for 92.2% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $4,147 and has fallen 99.3% since, to $28 in 2025.
Across 9 payments — averaging $484.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$4K
- Integra Lifesciences Corporation$156
- GSK$79
- Johnson & Johnson$38
- Stryker$28
- Bausch & Lomb Americas Inc.$20
- plus $20 from 1 others
Across 18 payments — averaging $46,659 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi$720K
- Sanofi US Services Inc.$120K
What the payments were for
- Consulting fees$3,91290%
- Food & beverage$44910%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 2 | $4,020 |
| Integra Lifesciences Corporation | 2 | $156 |
| GSK | 1 | $79 |
| Johnson & Johnson | 1 | $38 |
| Stryker | 1 | $28 |
| Bausch & Lomb Americas Inc. | 1 | $20 |
| Baxter Healthcare | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$108
- Acclarent Aera$106
How this compares
Too few otolaryngic allergy providers in Georgiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 15 | $66,194 |
| Azelastine Hcl | 145 | $5,881 |
| Mometasone Furoate | 44 | $5,339 |
| Ipratropium Bromide | 96 | $5,223 |
| Fluticasone Propionate | 108 | $2,279 |
| Doxycycline Hyclate | 28 | $261 |
| Mupirocin | 24 | $176 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $124 |
| Omeprazole | 11 | $99 |
| Prednisone | 19 | $42 |
| Oxycodone Hcl | 15 | $33 |
Paid to pharmacies, not to this prescriber.
Other otolaryngic allergy in Decatur
- Sarah WiseAtlanta$77K
- John DelgaudioAtlanta$49K
- David DillardAthens$9K
- Michael SylvesterFayetteville$5K
- David OliverSavannah$5K
- Daniel SpielmanAtlanta$4K
- Michael CallahanGainesville$3K
- Kody BolkAtlanta$2K
- Emily BarrowAtlanta$1K
- Anthony BotrosAtlanta$820
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.